Market Overview:
The global anti-senescence therapy market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of age-related diseases, rising awareness about anti-senescence therapies, and technological advancements in the field of gene therapy and immunotherapy. The global anti-senescence therapy market is segmented on the basis of type into gene therapy, immunotherapy, and others. The gene therapy segment is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. This growth can be attributed to increasing investments by pharmaceutical companies in this area and technological advancements in this field. The immunotherapy segment is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. This growth can be attributedto rising awareness about its benefits among patients and healthcare professionalsand technological advancementsin this field.
Product Definition:
Anti-senescence therapy is a treatment that helps to prevent or delay the onset of age-related conditions and diseases. It is important because it can help people stay healthy and active as they get older.
Gene Therapy:
Gene therapy is a new and innovative medical technology that involves the use of DNA as a therapeutic agent to treat genetic diseases, which are not able to be treated with the conventional methods. The basic principle behind this technology is that genes can be used to replace or supplement the body's own immune system in order to fight against disease.
Immunotherapy:
Immunotherapy is a treatment wherein the body's immune system is activated and encouraged to fight cancerous cells. There are various types of immunotherapies, including checkpoint inhibitors, cytokine therapies, bispecific antibodies, T-cell therapy etc. Checkpoint inhibitors are used in cases where the patient's immune system has been damaged due to chemotherapy or radiation therapy; they help restore the normal functioning of checkpoints that have been disabled by these treatments.
Application Insights:
The anti-senescence therapy market is categorized based on application into cardiovascular diseases, neural degenerative diseases, ophthalmology disorders, and others. Cardiovascular diseases segment held the largest share in 2017 owing to the increasing prevalence of target population (elderly people) which increases the risk of developing cardiovascular disorders. Moreover, this segment is expected to grow at a lucrative rate during forecast period due to introduction of new products such as gene therapies for cardiology and neurology associated disorders.
On the other hand, ophthalmology disorder segment is expected to witness fastest growth rate during forecast period due to increase in number of patients suffering from vision impairment or blindness which requires effective treatment with anti-aging drugs. In addition, presence of key players such as Allergan plc., Eye Bank Association Of America And Research Foundation For The Blind And Macular Degeneration and Pfizer Inc., among others are anticipated to boost industry growth over next eight years.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of clinical trial participants and research institutes involved in anti-senescence therapy development. The U.S.
Asia Pacific is expected to witness significant growth during the forecast period owing to increasing healthcare expenditure levels and rising awareness about these therapies among patients suffering from chronic diseases such as cancer, diabetes & cardiovascular disorders.
The major countries contributing towards revenue generation are China, Japan, South Korea.
Growth Factors:
- Increasing geriatric population: The global geriatric population is expected to grow at a CAGR of 6.5% from 2016 to 2020, reaching 1.6 billion by 2020. This will create a large pool of potential patients for anti-senescence therapies and drive the market growth.
- Rising awareness about anti-aging therapies: There is an increasing awareness among people about the benefits of anti-aging therapies and this is driving the demand for such treatments.
- Technological advancements in senolytic therapy: Senolytic therapy is one of the most promising areas of research in aging and there have been significant advancements in this area in recent years, which is likely to drive market growth over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Anti-Senescence Therapy Market Research Report
By Type
Gene Therapy, Immunotherapy, Others
By Application
Cardiovascular Diseases, Neural Degenerative Diseases, Ophthalmology Disorders, Others
By Companies
Unity Biotechnology, Siwa Therapeutics, Calico LLC, AgeX Therapeutics，Inc, Numeric Biotech, Human Longevity, Inc. (HLI), Cleara Biotech, OisinBiotechnologies, Recursion Pharmaceuticals, Sierra Sciences, Proteostasis Therapeutics, Senolytic Therapeutics, Allergan
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
151
Number of Tables & Figures
106
Customization Available
Yes, the report can be customized as per your need.
Global Anti-Senescence Therapy Market Report Segments:
The global Anti-Senescence Therapy market is segmented on the basis of:
Types
Gene Therapy, Immunotherapy, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiovascular Diseases, Neural Degenerative Diseases, Ophthalmology Disorders, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Unity Biotechnology
- Siwa Therapeutics
- Calico LLC
- AgeX Therapeutics，Inc
- Numeric Biotech
- Human Longevity, Inc. (HLI)
- Cleara Biotech
- OisinBiotechnologies
- Recursion Pharmaceuticals
- Sierra Sciences
- Proteostasis Therapeutics
- Senolytic Therapeutics
- Allergan
Highlights of The Anti-Senescence Therapy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Gene Therapy
- Immunotherapy
- Others
- By Application:
- Cardiovascular Diseases
- Neural Degenerative Diseases
- Ophthalmology Disorders
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Anti-Senescence Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Anti-senescence therapy is a type of cancer treatment that uses drugs or surgery to stop the growth of tumors.
Some of the major companies in the anti-senescence therapy market are Unity Biotechnology, Siwa Therapeutics, Calico LLC, AgeX Therapeutics，Inc, Numeric Biotech, Human Longevity, Inc. (HLI), Cleara Biotech, OisinBiotechnologies, Recursion Pharmaceuticals, Sierra Sciences, Proteostasis Therapeutics, Senolytic Therapeutics, Allergan.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Anti-Senescence Therapy Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Anti-Senescence Therapy Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Anti-Senescence Therapy Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Anti-Senescence Therapy Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Anti-Senescence Therapy Market Size & Forecast, 2018-2028
4.5.1 Anti-Senescence Therapy Market Size and Y-o-Y Growth
4.5.2 Anti-Senescence Therapy Market Absolute $ Opportunity
Chapter 5 Global Anti-Senescence Therapy Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Anti-Senescence Therapy Market Size Forecast by Type
5.2.1 Gene Therapy
5.2.2 Immunotherapy
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Anti-Senescence Therapy Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Anti-Senescence Therapy Market Size Forecast by Applications
6.2.1 Cardiovascular Diseases
6.2.2 Neural Degenerative Diseases
6.2.3 Ophthalmology Disorders
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Anti-Senescence Therapy Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Anti-Senescence Therapy Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Anti-Senescence Therapy Analysis and Forecast
9.1 Introduction
9.2 North America Anti-Senescence Therapy Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Anti-Senescence Therapy Market Size Forecast by Type
9.6.1 Gene Therapy
9.6.2 Immunotherapy
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Anti-Senescence Therapy Market Size Forecast by Applications
9.10.1 Cardiovascular Diseases
9.10.2 Neural Degenerative Diseases
9.10.3 Ophthalmology Disorders
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Anti-Senescence Therapy Analysis and Forecast
10.1 Introduction
10.2 Europe Anti-Senescence Therapy Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Anti-Senescence Therapy Market Size Forecast by Type
10.6.1 Gene Therapy
10.6.2 Immunotherapy
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Anti-Senescence Therapy Market Size Forecast by Applications
10.10.1 Cardiovascular Diseases
10.10.2 Neural Degenerative Diseases
10.10.3 Ophthalmology Disorders
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Anti-Senescence Therapy Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Anti-Senescence Therapy Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Anti-Senescence Therapy Market Size Forecast by Type
11.6.1 Gene Therapy
11.6.2 Immunotherapy
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Anti-Senescence Therapy Market Size Forecast by Applications
11.10.1 Cardiovascular Diseases
11.10.2 Neural Degenerative Diseases
11.10.3 Ophthalmology Disorders
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Anti-Senescence Therapy Analysis and Forecast
12.1 Introduction
12.2 Latin America Anti-Senescence Therapy Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Anti-Senescence Therapy Market Size Forecast by Type
12.6.1 Gene Therapy
12.6.2 Immunotherapy
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Anti-Senescence Therapy Market Size Forecast by Applications
12.10.1 Cardiovascular Diseases
12.10.2 Neural Degenerative Diseases
12.10.3 Ophthalmology Disorders
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Anti-Senescence Therapy Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Anti-Senescence Therapy Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Anti-Senescence Therapy Market Size Forecast by Type
13.6.1 Gene Therapy
13.6.2 Immunotherapy
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Anti-Senescence Therapy Market Size Forecast by Applications
13.10.1 Cardiovascular Diseases
13.10.2 Neural Degenerative Diseases
13.10.3 Ophthalmology Disorders
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Anti-Senescence Therapy Market: Competitive Dashboard
14.2 Global Anti-Senescence Therapy Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Unity Biotechnology
14.3.2 Siwa Therapeutics
14.3.3 Calico LLC
14.3.4 AgeX Therapeutics，Inc
14.3.5 Numeric Biotech
14.3.6 Human Longevity, Inc. (HLI)
14.3.7 Cleara Biotech
14.3.8 OisinBiotechnologies
14.3.9 Recursion Pharmaceuticals
14.3.10 Sierra Sciences
14.3.11 Proteostasis Therapeutics
14.3.12 Senolytic Therapeutics
14.3.13 Allergan
